MedPath

Comparison Between Two Fertility Protocols in Obese Polycystic Ovary Syndrome Patients

Not Applicable
Conditions
Obese
Infertility
Polycystic Ovary Syndrome
Interventions
Procedure: IVF (In Vitro Fertilization) Antagonist Protocol
Procedure: IVM (In Vitro Maturation) Treatment
Registration Number
NCT01473459
Lead Sponsor
Hillel Yaffe Medical Center
Brief Summary

The purpose of this study is to compare two fertility protocols in obese women with Polycystic Ovarian Syndrome who are candidates for In Vitro Fertilization (IVF). These protocols carry less risk of ovarian hyperstimulation syndrome which these women may experience.

Detailed Description

The purpose of this study is to compare two fertility protocols in obese women with Polycystic Ovarian Syndrome who are candidates for In Vitro Fertilization (IVF). These protocols carry less risk of ovarian hyperstimulation syndrome which these women may experience.The patients in the IVM group will not be exposeD to gonadotropin treatment for controlled ovarian hyperstimulation. In the antagonist group we will use GnRH agonist to induce ovulation which may reduce the risk for ovarian hyperstimulation.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • BMI > 30
  • PCOS
  • Failure of COH treatment
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Antagonist ProtocolIVF (In Vitro Fertilization) Antagonist Protocol-
IVM TreatmentIVM (In Vitro Maturation) Treatment-
Primary Outcome Measures
NameTimeMethod
Fertility resultsOne year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hillel Yaffe Medical Center

🇮🇱

Hadera, Israel

© Copyright 2025. All Rights Reserved by MedPath